Skip to main content

Table 3 Patients’ medication at the beginning of the study

From: Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain

Medication at beginning of the study

CLBP (n = 19)

NeP (n = 19)

Ibuprofen (no. (%))

3 (16)

2 (11)

Diclofenac (no. (%))

2 (11)

3 (16)

Paracetamol (no. (%))

3 (16)

2 (11)

Metamizole (no. (%))

1 (5)

1 (5)

Opioids (no. (%))

2 (11)

3 (16)

Pregabalin (no. (%))

0 (0)

1 (5)

Duloxetine (no. (%))

0 (0)

1 (5)

  1. There is no significant difference in the intake of analgesics or coanalgesics in patients with CLBP and NeP. Data are presented as mean ± SD, n = 19, statistical testing was performed using Fisher’s exact test
  2. CLBP chronic low back pain; NeP neuropathic pain (symmetrical polyneuropathy, peripheral mononeuropathy, postherpetic neuralgia, orofacial pain)
Back to article page